Pulmonary Research Institute of Southeast Michigan Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Farmington Hills MI United States (2007)

Organization Overview

First Clinical Trial
2014
NCT02157935
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Pulmonary Research Institute of Southeast Michigan

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Respiratory Aspiration (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7